Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Childhood obesity is now officially outpacing underweight globally — and Novo Nordisk is putting money behind the fight. The Danish pharma giant is committing an additional $18 million to its UNICEF partnership to fund prevention programs across seven countries from 2027 to 2030. The initiative aims to reach more than 80 million children through nutrition counseling, physical activity programs, and mental health support.
Childhood obesity has crossed a historic threshold — for the first time on record, it now affects more children globally than underweight, according to UNICEF's 2025 Child Nutrition Report. In response, Novo Nordisk is doubling down on its partnership with UNICEF, pledging an additional $18 million to expand prevention efforts across seven countries: Mexico, Colombia, Indonesia, the Philippines, India, Egypt, and Kenya.
The four-year program (2027–2030), with funding kicking off in 2026, will focus on upstream interventions — think nutrition and physical activity counseling, plus basic mental health screening and support. The expansion is also tied to Novo Nordisk's updated sustainability strategy, set to launch next week, signaling that tackling obesity is becoming a core part of the company's broader corporate mission — not just its drug portfolio.
By the Numbers:
Why it matters: With childhood obesity now a larger global burden than undernutrition, prevention-focused partnerships like this one are critical. Reaching 80 million children with early interventions could meaningfully reduce long-term cardiometabolic disease risk — and reshape how the healthcare system approaches obesity before it starts.
